Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti
Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
Myfortic for the Treatment of Non-infectious Intermediate Uveitis
Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Methotrexate and Mycophenolate Mofetil for UVEITIS
† Study has passed its completion date and status has not been verified in more than two years.